Veterinary Medicine Information website

Intra-epicaine 20 mg/ml solution injectable pour chevaux

Authorised
  • Mepivacaine hydrochloride
Download as PDF

Product identification

Medicine name:
Intra-epicaine 20 mg/ml solution injectable pour chevaux
Active substance:
  • Mepivacaine hydrochloride
Target species:
  • Horse
Route of administration:
  • Intraarticular use
  • Epidural use

Product details

Active substance and strength:
  • Mepivacaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intraarticular use
    • Horse
      • Meat and offal, milk
        2
        day
  • Epidural use
    • Horse
      • Meat and offal, milk
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Clear type I glass vial containing 10 ml, with a red chlorobutyl rubber stopper and aluminium seal, available in carton of six.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 914/18/06/1700
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 23/10/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 23/10/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 23/10/2023
Download